Citations (84)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Junhui Xu, Liang Gao, Miao Yan, Bingjie Wang, Zhengyang Song, Huihui Liu, Kunyan Sun, Lin Nong, Mangju Wang & Xinan Cen. (2021) Potential Role of Pleural Fluid Cytokine Profile in Myelomatous Pleural Effusions. OncoTargets and Therapy 14, pages 4545-4550.
Read now
Read now
Meng Pang, Chunyuan Li, Dong Zheng, Ying Wang, Jing Wang, Weilong Zhang, Fang Li & Hongmei Jing. (2020) S1PR2 Knockdown Promotes Migration and Invasion in Multiple Myeloma Cells via NF-κB Activation. Cancer Management and Research 12, pages 7857-7865.
Read now
Read now
Eli Muchtar, Hila Magen & Morie A. Gertz. (2017) High-risk multiple myeloma: a multifaceted entity, multiple therapeutic challenges. Leukemia & Lymphoma 58:6, pages 1283-1296.
Read now
Read now
Jian Li, Kai-Ni Shen, Wen-Rong Huang, Li-Hong Li, Huan Chen, Wen-Ming Chen, Kai-Yan Liu, Li Yu & Dao-Bin Zhou. (2014) Autologous stem cell transplant can overcome poor prognosis in patients with multiple myeloma with extramedullary plasmacytoma. Leukemia & Lymphoma 55:7, pages 1687-1690.
Read now
Read now
Philippe Moreau & Aaron Polliack. (2013) Extramedullary multiple myeloma: extraosseous relapse is extra “bad news,” but why?. Leukemia & Lymphoma 54:7, pages 1349-1350.
Read now
Read now
Jens Hillengass & Ola Landgren. (2013) Challenges and opportunities of novel imaging techniques in monoclonal plasma cell disorders: imaging “early myeloma”. Leukemia & Lymphoma 54:7, pages 1355-1363.
Read now
Read now
Matthew Weinstock & Irene M. Ghobrial. (2013) Extramedullary multiple myeloma. Leukemia & Lymphoma 54:6, pages 1135-1141.
Read now
Read now
Articles from other publishers (77)
V. V. Voytsekhovskiy, A. A. Grigorenko, T. V. Esenina, S. N. Roshchin, E. A. Filatova, N. A. Fedorova, V. A. Krivutsa, Ya. D. Zueva & M. V. Sayapina. (2023) Features of diagnostics and treatment of various plasmacytoma options. Bulletin Physiology and Pathology of Respiration:88, pages 105-119.
Crossref
Crossref
Jiro Kikuchi, Nobuyuki Kodama, Masataka Takeshita, Sho Ikeda, Takahiro Kobayashi, Yoshiaki Kuroda, Michihiro Uchiyama, Naoki Osada, Bjarne Bogen, Hiroshi Yasui, Naoto Takahashi, Akiyoshi Miwa & Yusuke Furukawa. (2023) EMD originates from hyaluronan-induced homophilic interactions of CD44 variant-expressing MM cells under shear stress. Blood Advances 7:4, pages 508-524.
Crossref
Crossref
Martin Stork, Sabina Sevcikova, Tomas Jelinek, Jiri Minarik, Jakub Radocha, Tomas Pika, Lenka Pospisilova, Ivan Spicka, Jan Straub, Petr Pavlicek, Alexandra Jungova, Zdenka Knechtova, Viera Sandecka, Vladimir Maisnar, Roman Hajek & Ludek Pour. (2022) Unexpected Heterogeneity of Newly Diagnosed Multiple Myeloma Patients with Plasmacytomas. Biomedicines 10:10, pages 2535.
Crossref
Crossref
Raquel Jiménez-Segura, Laura Rosiñol, Ma Teresa Cibeira, Carlos Fernández de Larrea, Natalia Tovar, Luis Gerardo Rodríguez-Lobato, Esther Bladé, David F. Moreno, Aina Oliver-Caldés & Joan Bladé. (2022) Paraskeletal and extramedullary plasmacytomas in multiple myeloma at diagnosis and at first relapse: 50-years of experience from an academic institution. Blood Cancer Journal 12:9.
Crossref
Crossref
Yating Li, Zhengxu Sun & Xiaoyan Qu. (2022) Advances in the treatment of extramedullary disease in multiple myeloma. Translational Oncology 22, pages 101465.
Crossref
Crossref
Vincenzo Sammartano, Alfonso Cerase, Valentina Venanzi, Maria Antonietta Mazzei, Beatrice Esposito Vangone, Francesco Gentili, Ivano Chiarotti, Monica Bocchia & Alessandro Gozzetti. (2022) Central Nervous System Myeloma and Unusual Extramedullary Localizations: Real Life Practical Guidance. Frontiers in Oncology 12.
Crossref
Crossref
Stefan Forster & Ramin Radpour. (2022) Molecular Impact of the Tumor Microenvironment on Multiple Myeloma Dissemination and Extramedullary Disease. Frontiers in Oncology 12.
Crossref
Crossref
Daniela N. Petrusca, Kelvin P. Lee & Deborah L. Galson. (2022) Role of Sphingolipids in Multiple Myeloma Progression, Drug Resistance, and Their Potential as Therapeutic Targets. Frontiers in Oncology 12.
Crossref
Crossref
Shuang Gao, Qihui Li, Fei Dong, Ping Yang, Yingtong Chen, Jing Wang, Yanfang Wang & Hongmei Jing. (2022) Clinical characteristics and survival outcomes of newly diagnosed multiple myeloma patients presenting with extramedullary disease: A retrospective study. Leukemia Research 115, pages 106793.
Crossref
Crossref
Liang Gao, Junhui Xu, Weiwei Xie, Bingjie Wang, Xinan Cen & Mangju Wang. (2022) Clinical Characteristics and Prognosis of Multiple Myeloma With Myelomatous Pleural Effusion: A Retrospective Single-Center Study. Technology in Cancer Research & Treatment 21, pages 153303382211323.
Crossref
Crossref
Ankush Bhatia & Nina A. Paleologos. 2022. Neurological Complications of Systemic Cancer and Antineoplastic Therapy. Neurological Complications of Systemic Cancer and Antineoplastic Therapy
415
431
.
Alice C. Shieh, Navid Faraji, Daniel Smith, Keval Parikh & Nikhil H. Ramaiya. (2021) Utility and Clinical Implications of Appendicular Skeleton Magnetic Resonance Imaging in Multiple Myeloma: A Single-Institutional 15-Year Experience. Journal of Computer Assisted Tomography 45:6, pages 904-911.
Crossref
Crossref
Al‐Ola Abdallah, Ghulam Rehman Mohyuddin, Nausheen Ahmed, Meera Mohan, Wei Cui, Leyla Shune, Zahra Mahmoudjafari, Joseph McGuirk, Siddhartha Ganguly & Shebli Atrash. (2021) Outcomes of VDPACE with an immunomodulatory agent as a salvage therapy in relapsed/refractory multiple myeloma with extramedullary disease. eJHaem 2:4, pages 757-764.
Crossref
Crossref
Laura Rosiñol, Meral Beksac, Elena Zamagni, Niels W. C. J. Van de Donk, Kenneth C. Anderson, Ashraf Badros, Jo Caers, Michele Cavo, Meletios‐Athanasios Dimopoulos, Angela Dispenzieri, Hermann Einsele, Monika Engelhardt, Carlos Fernández de Larrea, Gösta Gahrton, Francesca Gay, Roman Hájek, Vania Hungria, Artur Jurczyszyn, Nicolaus Kröger, Robert A. Kyle, Fernando Leal da Costa, Xavier Leleu, Suzanne Lentzsch, Maria V. Mateos, Giampaolo Merlini, Mohamad Mohty, Philippe Moreau, Leo Rasche, Donna Reece, Orhan Sezer, Pieter Sonneveld, Saad Z. Usmani, Karin Vanderkerken, David H. Vesole, Anders Waage, Sonja Zweegman, Paul G. Richardson & Joan Bladé. (2021) Expert review on soft‐tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations. British Journal of Haematology 194:3, pages 496-507.
Crossref
Crossref
Hee Jeong Cho, Dong Won Baek, Ju-Hyung Kim, Jungmin Lee, Yu Kyung Chung, Sung-Hoon Jung, Ga-young Song, Seo-Yeon Ahn, Jae Sook Ahn, Deok-Hwan Yang, Je-Jung Lee, Hyeong-Joon Kim, Chae Moon Hong, Shin Young Jeong, Jung-Joon Min, Sang-Kyun Sohn & Joon Ho Moon. (2021) Favorable long-term outcomes with autologous stem cell transplantation for high-risk multiple myeloma patients with a positive result on 18F-FDG PET/CT at baseline. Clinical Lymphoma Myeloma and Leukemia.
Crossref
Crossref
JingSong He, XiaoYan Yue, DongHua He, Yi Zhao, Yang Yang, GaoFeng Zheng, Enfan Zhang, XiaoYan Han, WenJun Wu, Li Yang, Jing Chen & Zhen Cai. (2021) Multiple Extramedullary-Bone Related and/or Extramedullary Extraosseous Are Independent Poor Prognostic Factors in Patients With Newly Diagnosed Multiple Myeloma. Frontiers in Oncology 11.
Crossref
Crossref
Virginia Bove, David Garrido & Eloisa Riva. (2021) Young age and autologous stem cell transplantation are associated with improved survival in newly diagnosed multiple myeloma. Hematology, Transfusion and Cell Therapy 43:3, pages 295-302.
Crossref
Crossref
Motoharu Shibusawa & Tetsuya Tanimoto. (2021) Multiple myeloma triplet therapies: baseline characteristics and control groups. The Lancet 397:10285, pages 1621.
Crossref
Crossref
Dickran Kazandjian, Alexander Dew, Elizabeth Hill, Elizabeth Gil Ramirez, Candis Morrison, Esther Mena, Liza Lindenberg, Constance Yuan, Irina Maric, Hao-Wei Wang, Katherine Calvo, Alina Dulau-Florea, Joseph Roswarski, Michael Emanuel, Raul Braylan, Baris Turkbey, Peter Choyke, Kevin Camphausen, Maryalice Stetler-Stevenson, Seth M. Steinberg, William D. Figg & Jennifer Jones. (2021) Avelumab, a PD-L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refractory Multiple Myeloma. The Oncologist 26:4, pages 288-e541.
Crossref
Crossref
Ehud Fliss, Arik Zaretski, Yael Cohen, Yuval Shapira, Eyal Gur & Ravit Yanko. (2021) Outside the box—Surgery for aggressive plasmacytoma in scar. Clinical Case Reports 9:3, pages 1325-1329.
Crossref
Crossref
Guang Li, Yan-Ping Song, Yao Lv, Zhen-Zhen Li & Yan-Hua Zheng. (2021) Clinical Characteristics and Prognostic Analysis of Multiple Myeloma with Extramedullary Disease: A SEER-Based Study. Journal of Oncology 2021, pages 1-9.
Crossref
Crossref
Long Di, Kevin Huang, Tigran Kesayan, Derek Kroll, Rachid C. Baz, Robert J. Macaulay & Nam D. Tran. (2020) Multiple myeloma presenting as an intramedullary spinal cord tumor: a case report and review of the literature. Journal of Medical Case Reports 14:1.
Crossref
Crossref
Maiia V. Firsova, Larisa P. Mendeleeva, Alla M. Kovrigina, Maxim V. Solovev & Valery G. Savchenko. (2020) Plasmacytoma in patients with multiple myeloma: morphology and immunohistochemistry. BMC Cancer 20:1.
Crossref
Crossref
Jongheon Jung, Yoon Seok Choi, Jae Hoon Lee, Won Sik Lee, Sung-hyun Kim, Yong Park, Seung-Shin Lee, Young Rok Do, Jae-Cheol Jo, Je-Jung Lee, Jin Seok Kim, Ho-Jin Shin, Dong-Yeop Shin, Sung-Soo Yoon, Chang-Ki Min, Kihyun Kim & Hyeon-Seok Eom. (2020) Autologous stem cell transplantation in elderly patients with multiple myeloma in Korea: the KMM1807 study. International Journal of Hematology 112:1, pages 84-95.
Crossref
Crossref
Colin MarshallNathan FrantzElias KikanoDaniel A. SmithEzgi GulerSree Harsha TirumaniNikhil H. Ramaiya. (2020) The Role of Imaging and Systemic Treatments in Myeloma: A Primer for Radiologists. American Journal of Roentgenology 214:6, pages 1321-1334.
Crossref
Crossref
Megan H. Jagosky & Saad Z. Usmani. (2020) Extramedullary Disease in Multiple Myeloma. Current Hematologic Malignancy Reports 15:2, pages 62-71.
Crossref
Crossref
MihaelaMaria Ghinea, AndreeaGeorgiana Stoica & SabinaLivia Ciocodei. (2020) From symptom and sign to diagnosis in a case of pulmonary plasmacytoma and pulmonary metastasis. Lung India 37:1, pages 72.
Crossref
Crossref
Uros Markovic, Valeria Calafiore, Enrica Martino, Rachele Giubbolini, Marina Silvia Parisi, Alessandra Romano, Vittorio Del Fabro, Francesco Di Raimondo & Concetta Conticello. (2019) A rare case of multiple myeloma with intracranial extramedullary relapse: One or more myeloma clones?. Clinical Case Reports 7:9, pages 1629-1636.
Crossref
Crossref
Raquel Jiménez‐Segura, Miquel Granell, Mercè Gironella, Eugenia Abella, Antoni García‐Guiñón, Albert Oriol, Elena Cabezudo, Victoria Clapés, Joan Alfons Soler, Lourdes Escoda, Jordi López-Pardo, Carlos Fernández de Larrea, Maria Teresa Cibeira, Natalia Tovar, Ignacio Isola, Joan Bladé & Laura Rosiñol. (2019) Pomalidomide‐dexamethasone for treatment of soft‐tissue plasmacytomas in patients with relapsed / refractory multiple myeloma. European Journal of Haematology 102:5, pages 389-394.
Crossref
Crossref
Junichiro Takano, Sohtaro Mine, Makoto Mochizuki, Noriko Tanaka & Shotaro Hagiwara. (2018) Late-stage myeloma invades kidney without significant effect on renal function: findings from 53 autopsies in a single institute. International Journal of Hematology 109:2, pages 147-153.
Crossref
Crossref
Muhammad Sardar, Nasreen Shaikh, Saad Ullah Malik, Warda Faridi, Eli Balshan & Mihir Maniar. (2019) Progressive left lower extremity weakness in a patient with multiple myeloma: A diagnostic dilemma. SAGE Open Medical Case Reports 7, pages 2050313X1983350.
Crossref
Crossref
Ajay K. Nooka & Sagar Lonial. (2019) Mechanism of Action and Novel IMiD-Based Compounds and Combinations in Multiple Myeloma. The Cancer Journal 25:1, pages 19-31.
Crossref
Crossref
Dangui Chen, Bing Chen & Fusheng Yao. (2018) Doxorubicin-Loaded PEG-CdTe Quantum Dots as a Smart Drug Delivery System for Extramedullary Multiple Myeloma Treatment. Nanoscale Research Letters 13:1.
Crossref
Crossref
Min Ho Cho, Rohan Mandaliya, Jennifer Tran, Wen Lee & Mitesh Patel. (2018) Biliary Obstruction due to a Pancreatic Plasmacytoma. Case Reports in Gastrointestinal Medicine 2018, pages 1-3.
Crossref
Crossref
Michael Bento Schmid & Lucie Kopfstein. (2018) From carcinoma through lymphoma to myeloma: a gastric mass diagnostic rollercoaster ride. BMJ Case Reports, pages bcr-2018-224953.
Crossref
Crossref
M. V. Firsova, L. P. Mendeleeva, A. M. Kovrigina, N. I. Deyneko, M. V. Soloviev, E. G. Gemdzhyan & V. G. Savchenko. (2018) MORPHOLOGICAL FEATURES OF TUMORS SUBSTRATE IN MULTIPLE MYELOMA PATIENTS COMPLICATED WITH PLASMACYTOMA. Oncohematology 13:2, pages 73-81.
Crossref
Crossref
Despina Fotiou, Meletios A. Dimopoulos & Efstathios Kastritis. (2018) How We Manage Patients with Plasmacytomas. Current Hematologic Malignancy Reports 13:3, pages 227-235.
Crossref
Crossref
Joan Bladé & Laura Rosiñol. 2018. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood
585
593
.
Morie A. Gertz, Laura Rosinol & Joan Bladé. 2018. Multiple Myeloma and Other Plasma Cell Neoplasms. Multiple Myeloma and Other Plasma Cell Neoplasms
157
175
.
Zeljko Todorovic, Milena Jovanovic, Dusan Todorovic, Anita Ivosevic, Marina Markovic, Drakce Radovanovic, Danijela Jovanovic, Vesna Cemerikic & Predrag Djurdjevic. (2017) Extramedullary Involvement of Lymph Nodes in Multiple Myeloma. Serbian Journal of Experimental and Clinical Research 18:3, pages 257-261.
Crossref
Crossref
Joselle Cook, Steven Song, Anthony Ventimiglia & Carol Luhrs. (2017) Incidental Discovery of Multiorgan Extramedullary Plasmacytomas in the Setting of Newly Diagnosed Multiple Myeloma and Delayed Hemolytic Transfusion Reaction. Case Reports in Hematology 2017, pages 1-4.
Crossref
Crossref
Ajay K. NookaSagar Lonial. (2016) New Targets and New Agents in High-Risk Multiple Myeloma. American Society of Clinical Oncology Educational Book:36, pages e431-e441.
Crossref
Crossref
Jian-Zhu Yang, Wei-Guang Lian, Li-Xia Sun, Dian-Wen Qi, Yang Ding & Xiang-Hong Zhang. (2016) High nuclear expression of Twist1 in the skeletal extramedullary disease of myeloma patients predicts inferior survival. Pathology - Research and Practice 212:3, pages 210-216.
Crossref
Crossref
Daniela Sciancalepore, Sergio Musci, Maria Rosaria Fracella, Grazia D’Alesio, Azzurra Sportelli, Giuseppe Ingravallo, Angelo Vacca & Roberto Ria. (2016) Extramedullary Plasmacytoma Mimicking Pancreatic Cancer: An Unusual Presentation. Case Reports in Oncological Medicine 2016, pages 1-5.
Crossref
Crossref
Eli Muchtar, Moshe E. Gatt, Ory Rouvio, Chezi Ganzel, Evgeni Chubar, Celia Suriu, Tamar Tadmor, Olga Shevetz, Noa Lavi, Tzippy Shochat, Yael C. Cohen, Irit Avivi, Pia Raanani & Hila Magen. (2016) Efficacy and safety of salvage therapy using Carfilzomib for relapsed or refractory multiple myeloma patients: a multicentre retrospective observational study. British Journal of Haematology 172:1, pages 89-96.
Crossref
Crossref
Luis Martí-Bonmatí, Cristina Ramirez-Fuentes, Ángel Alberich-Bayarri & Cristina Ruiz-Llorca. (2015) State-of-the-art of bone marrow imaging in multiple myeloma. Current Opinion in Oncology 27:6, pages 540-550.
Crossref
Crossref
. (2015) New era in staging/treatment of multiple myeloma. American Journal of BioMedicine 3:4, pages 541-553.
Crossref
Crossref
Sabina Sevcikova, Helena Paszekova, Lenka Besse, Lenka Sedlarikova, Veronika Kubaczkova, Martina Almasi, Ludek Pour & Roman Hajek. (2015) Extramedullary relapse of multiple myeloma defined as the highest risk group based on deregulated gene expression data. Biomedical Papers 159:2, pages 288-293.
Crossref
Crossref
Joan Bladé, Carlos Fernández de Larrea & Laura Rosiñol. (2015) Extramedullary disease in multiple myeloma in the era of novel agents. British Journal of Haematology 169:6, pages 763-765.
Crossref
Crossref
Cindy Varga, Wanling Xie, Jacob Laubach, Irene M. Ghobrial, Elizabeth K. O'Donnell, Matthew Weinstock, Claudia Paba-Prada, Diane Warren, Michelle E. Maglio, Robert Schlossman, Nikhil C. Munshi, Noopur Raje, Edie Weller, Kenneth C. Anderson, Constantine S. Mitsiades & Paul G. Richardson. (2015) Development of extramedullary myeloma in the era of novel agents: no evidence of increased risk with lenalidomide-bortezomib combinations. British Journal of Haematology 169:6, pages 843-850.
Crossref
Crossref
Jiajia Zhang & Yuping Zhong. (2015) Clinical analysis of 36 multiple myeloma patients with extramedullary plasmacytoma invasion of the spinal canal. Hematological Oncology 33:2, pages 75-79.
Crossref
Crossref
Shuhui Deng, Yan Xu, Gang An, Weiwei Sui, Dehui Zou, Yaozhong Zhao, Junyuan Qi, Fei Li, Mu Hao & Lugui Qiu. (2015) Features of Extramedullary Disease of Multiple Myeloma: High Frequency of P53 Deletion and Poor Survival: A Retrospective Single-Center Study of 834 Cases. Clinical Lymphoma Myeloma and Leukemia 15:5, pages 286-291.
Crossref
Crossref
Patrick J. Peller. (2015) Multiple Myeloma. PET Clinics 10:2, pages 227-241.
Crossref
Crossref
Ho-Jin Shin, Kihyun Kim, Je-Jung Lee, Moo-Kon Song, Eun Yup Lee, Sang Hyuk Park, Sun-Hee Kim, Mi-Ae Jang, Seok Jin Kim & Joo Seop Chung. (2015) The t(11;14)(q13;q32) Translocation as a Poor Prognostic Parameter for Autologous Stem Cell Transplantation in Myeloma Patients With Extramedullary Plasmacytoma. Clinical Lymphoma Myeloma and Leukemia 15:4, pages 227-235.
Crossref
Crossref
Joan Bladé, Laura Rosiñol & Carlos Fernández de Larrea. (2015) How I treat relapsed myeloma. Blood 125:10, pages 1532-1540.
Crossref
Crossref
Sung-Eun Lee, Jung-Ho Kim, Young-Woo Jeon, Jae-Ho Yoon, Seung-Hwan Shin, Ki-Seong Eom, Yoo-Jin Kim, Hee-Je Kim, Seok Lee, Seok-Goo Cho, Jong Wook Lee, Woo-Sung Min, Chong-Won Park & Chang-Ki Min. (2014) Impact of extramedullary plasmacytomas on outcomes according to treatment approach in newly diagnosed symptomatic multiple myeloma. Annals of Hematology 94:3, pages 445-452.
Crossref
Crossref
Diana Triantafyllopoulou, Stuart Mellor, Catherine Cargo, Ioannis Gkikas, Jagdish Adiyodi, Ayub Ali Bin, Neil Sahasrabudhe & Margaret Rokicka. (2015) Nonsecretory Multiple Myeloma Presenting as an Intestinal Tumor. Case Reports in Hematology 2015, pages 1-5.
Crossref
Crossref
Xiaoyan Qu, Lijuan Chen, Hairong Qiu, Hua Lu, Hanxin Wu, Hongxia Qiu, Peng Liu, Rui Guo & Jianyong Li. (2015) Extramedullary Manifestation in Multiple Myeloma Bears High Incidence of Poor Cytogenetic Aberration and Novel Agents Resistance. BioMed Research International 2015, pages 1-7.
Crossref
Crossref
Matthew J. Pianko, Evangelos Terpos, G. David Roodman, Chaitanya R. Divgi, Sonja Zweegman, Jens Hillengass & Suzanne Lentzsch. (2014) Whole-Body Low-Dose Computed Tomography and Advanced Imaging Techniques for Multiple Myeloma Bone Disease. Clinical Cancer Research 20:23, pages 5888-5897.
Crossref
Crossref
Isabel Ruth Preeshagul, Koen Van Besien & Tomer M. Mark. (2014) Controversies in Multiple Myeloma: to Transplant or Not?. Current Hematologic Malignancy Reports 9:4, pages 360-367.
Crossref
Crossref
Ho-Jin Shin, Kihyun Kim, Ji Won Lee, Moo-Kon Song, Je-Jung Lee, Ho-Sup Lee, Won Sik Lee, Seok Jin Kim & Joo Seop Chung. (2014) Comparison of outcomes after autologous stem cell transplantation between myeloma patients with skeletal and soft tissue plasmacytoma. European Journal of Haematology 93:5, pages 414-421.
Crossref
Crossref
Jian-Zhu Yang, Yan Li, Li-Xia Sun, Jie Fang, Ling-Juan Kong & Jin-Qiao Zhang. (2014) Interleukin-17 receptor expression on vascular endothelial cells of masses of skeletal extramedullary disease in myeloma patients. Pathology - Research and Practice 210:9, pages 586-590.
Crossref
Crossref
Yijin Jereme Gan, Akhil Chopra & Jeevendra Kanagalingam. (2014) Subglottic Extramedullary Plasmacytoma With Light Chain Multiple Myeloma Masquerading as Adult-Onset Asthma. Journal of Voice 28:3, pages 394.e1-394.e4.
Crossref
Crossref
C Fernández de Larrea, R Jiménez, L Rosiñol, E Giné, N Tovar, M T Cibeira, F Fernández-Avilés, C Martínez, M Rovira & J Bladé. (2013) Pattern of relapse and progression after autologous SCT as upfront treatment for multiple myeloma. Bone Marrow Transplantation 49:2, pages 223-227.
Crossref
Crossref
Thorsten Derlin. (2014) Imaging of multiple myeloma: Current concepts. World Journal of Orthopedics 5:3, pages 272.
Crossref
Crossref
Laura Rosiñol, Carlos Fernández de Larrea & Joan Bladé. (2014) Extramedullary Myeloma Spread Triggered by Surgical Procedures: An Emerging Entity?. Acta Haematologica 132:1, pages 36-38.
Crossref
Crossref
Jens Hillengass & Tobias Bäuerle. 2014. Functional Imaging in Oncology. Functional Imaging in Oncology
1335
1354
.
Bhasker Koppula, Justin Kaptuch & Christopher J. Hanrahan. (2013) Imaging of Multiple Myeloma: Usefulness of MRI and PET/CT. Seminars in Ultrasound, CT and MRI 34:6, pages 566-577.
Crossref
Crossref
Jan P. Pintoffl, Katja Weisel, Maximilian Schulze, Olga Maksimovic, Claus D. Claussen, Ulrich Kramer & Marius Horger. (2013) Role of Dynamic Contrast‐Enhanced Sonography for Characterization and Monitoring of Extramedullary Myeloma. Journal of Ultrasound in Medicine 32:10, pages 1777-1788.
Crossref
Crossref
B Wirk, J R Wingard & J S Moreb. (2012) Extramedullary disease in plasma cell myeloma: the iceberg phenomenon. Bone Marrow Transplantation 48:1, pages 10-18.
Crossref
Crossref
Joan Bladé & Laura Rosiñol. 2013. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood
665
680
.
Albert Oriol. (2011) Multiple myeloma with extramedullary disease. Advances in Therapy 28:S7, pages 1-6.
Crossref
Crossref
Beatriz Aguado, Belen Iñigo, Jose L. Sastre & Albert Oriol. (2011) Extramedullary plasmacytomas in the context of multiple myeloma. Advances in Therapy 28:S7, pages 7-13.
Crossref
Crossref
Joan BladéCarlos Fernández de LarreaLaura RosiñolMaría Teresa CibeiraRaquel JiménezRay Powles. (2011) Soft-Tissue Plasmacytomas in Multiple Myeloma: Incidence, Mechanisms of Extramedullary Spread, and Treatment Approach. Journal of Clinical Oncology 29:28, pages 3805-3812.
Crossref
Crossref
Matthew N. HallJyothi P. Jagannathan, Nikhil H. Ramaiya, Atul B. Shinagare & Annick D. Van den Abbeele. (2010) Imaging of Extraosseous Myeloma: CT, PET/CT, and MRI Features. American Journal of Roentgenology 195:5, pages 1057-1065.
Crossref
Crossref
Carlos Fernández De Larrea, Laura Rosiñol, María Teresa Cibeira, María Rozman, Montserrat Rovira & Joan Bladé. (2010) Extensive soft-tissue involvement by plasmablastic myeloma arising from displaced humeral fractures. European Journal of Haematology 85:5, pages 448-451.
Crossref
Crossref
M A Dimopoulos, E Kastritis, D Christoulas, M Migkou, M Gavriatopoulou, M Gkotzamanidou, M Iakovaki, C Matsouka, D Mparmparoussi, M Roussou, E Efstathiou & E Terpos. (2010) Treatment of patients with relapsed/refractory multiple myeloma with lenalidomide and dexamethasone with or without bortezomib: prospective evaluation of the impact of cytogenetic abnormalities and of previous therapies. Leukemia 24:10, pages 1769-1778.
Crossref
Crossref